BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 12, 2018
View Archived Issues
FDA grants orphan drug designation to LK-01 for the treatment of AML
Read More
XORTX files FDA pre-IND meeting request letter
Read More
New Dong-A compound shows activity against resistant Gram-negative bacteria
Read More
HIV-1 fusion peptide targeting, a promising vaccination strategy eliciting neutralizing antibodies
Read More
Phase III study of Vical's HSV-2 therapeutic vaccine does not meet primary endpoint
Read More
Preliminary data presented from interim review of phase I/II study of OXS-1550
Read More
Atogepant demonstrates efficacy and safety in phase IIb/III study in episodic migraine
Read More
FDA grants fast track designation to Betalutin for relapsed or refractory follicular lymphoma
Read More
Significant improvements in ulcerative colitis seen with apremilast in phase II trial
Read More
Boehringer Ingelheim initiates phase I study of BI-907828 in solid tumors
Read More
Phase III data support ibrutinib/rituximab combination in Waldenstrom's macroglobulinemia
Read More
Lilly and AstraZeneca discontinue phase III trials of lanabecestat for Alzheimer's disease
Read More
Merck KGaA reports promising phase II data for tepotinib in advanced HCC
Read More
EMA grants PRIME designation for Themis' Chikungunya vaccine
Read More
First-in-human data on FDL-176 in healthy subjects presented
Read More
NeuroRx completes phase IIb/III feasibility enrollment for NRX-101 in suicidal bipolar depression
Read More
Merck & Co. patents DGAT2 inhibitors
Read More
Arcus Biosciences presents CD73 inhibitors
Read More
FDA clears Arcus' INDs for AB-928 and AB-122
Read More
Retrotope begins compassionate use trials of RT-001
Read More
Aquinox initiates phase II study of rosiptor in chronic prostatitis/chronic pelvic pain syndrome
Read More
Takeda launches Azilect in Japan for Parkinson's disease
Read More
Apabetalone reverses HIV-1 latency and induces apoptosis of reservoir cells
Read More
New nonhuman primate model allows testing of antifibrotic therapeutic candidates
Read More
Cancer Research UK advances AST-VAC2 into phase I trial for NSCLC
Read More